Curiox Biosystems Co., Ltd (KOSDAQ:445680)

South Korea · Delayed Price · Currency is KRW

63,200

+9,200 (17.04%)

At close: Oct 21, 2026

Curiox Biosystems Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5,735	5,152	4,588	6,788	7,237	5,523
Revenue Growth	49.92%	12.29%	-32.41%	-6.21%	31.04%	25.97%
Gross Profit	2,813	2,135	2,559	3,825	4,733	3,494
Operating Income	-13,042	-12,314	-13,378	-10,557	-11,421	-8,337
Net Income	-12,780	-27,177	-8,089	-10,040	-11,495	-14,524
Earnings Per Share	-750.60	-1645.17	-503.00	-702.41	-1619.76	-1114.50
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
South Korea	41.4	5.18	6.43	4.48	242.78	5,523
outside of America	5,693	5,146	4,581	6,783	6,994	-
Total	5,735	5,152	4,588	6,788	7,237	5,523

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	10,501	17,785	28,188	17,909	8,722	19,819
Total Debt	517.58	2,450	8,142	965.16	387.21	30,446
Net Cash (Debt)	9,984	15,335	20,045	16,944	8,334	-10,627
Net Cash Growth	-26.05%	-23.50%	18.30%	103.30%	-	-
Net Cash Per Share	586.37	928.33	1246.49	1185.37	1174.42	-815.46

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-9,271	-11,109	-9,698	-8,164	-9,888	-5,126
Capital Expenditures	-78.82	-136.1	-257.88	-211.53	-822.86	-261.26
Free Cash Flow	-9,350	-11,245	-9,956	-8,376	-10,711	-5,387
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	49.05%	41.45%	55.77%	56.35%	65.40%	63.27%
Operating Margin	-227.43%	-239.04%	-291.61%	-155.53%	-157.81%	-150.95%
Pretax Margin	-223.49%	-530.56%	-174.29%	-150.43%	-156.01%	-266.04%
Profit Margin	-222.85%	-527.55%	-176.32%	-147.92%	-158.83%	-262.98%
FCF Margin	-163.04%	-218.29%	-217.02%	-123.39%	-148.00%	-97.54%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	189.60	388.82	65.23	59.45	-	-